Patient Guide: A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 80 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06032546
Status: TERMINATED
Condition: Human Immuno-deficiency Virus (HIV) Disease
Phase: PHASE2

Find a Study Location Near You

This study is available at 80 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Birmingham, Alabama
  • Bakersfield, California
  • Beverly Hills, California
  • • And 77 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily